|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 234.00 NOK | +2.63% |
|
+1.30% | -9.65% |
| 06-10 | Odin Small Cap gains 4.90 percent in May - slightly trims Mycronic position | FW |
| 05-12 | Danske Bank raises Medistim price target to NOK 320 (310), reiterates Buy - BN | FW |
Company Valuation: Medistim ASA
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 6,693 | 4,216 | 3,912 | 2,738 | 4,735 | 4,281 | - | - |
| Change | - | -37.01% | -7.22% | -30.01% | 72.95% | -9.6% | - | - |
| Enterprise Value (EV) 1 | 6,581 | 4,216 | 3,866 | 2,584 | 4,561 | 4,142 | 4,129 | 4,106 |
| Change | - | -35.93% | -8.31% | -33.16% | 76.51% | -9.19% | -0.31% | -0.56% |
| P/E | 73.8x | 37x | 37.7x | 26.4x | 29.7x | 25.6x | 23.9x | 21.4x |
| PBR | 21.9x | - | - | - | 10.1x | 8.73x | 7.85x | 7.12x |
| PEG | - | 1.5x | -4.13x | - | 0.6x | 5.31x | 3.28x | 1.8x |
| Capitalization / Revenue | 15.7x | 8.57x | 7.43x | 4.87x | 6.77x | 5.6x | 5.18x | 4.79x |
| EV / Revenue | 15.4x | 8.57x | 7.34x | 4.59x | 6.52x | 5.42x | 4.99x | 4.59x |
| EV / EBITDA | 47.1x | 25.6x | 24.9x | 16.6x | 20.6x | 17.1x | 15.7x | 14.1x |
| EV / EBIT | 56.6x | 29.8x | 29.4x | 19.7x | 23.2x | 19.1x | 17.7x | 15.7x |
| EV / FCF | 56.4x | - | 46.3x | 22.1x | 29.3x | 37.7x | 27.9x | 24.8x |
| FCF Yield | 1.77% | - | 2.16% | 4.52% | 3.41% | 2.66% | 3.58% | 4.03% |
| Dividend per Share 2 | 3.75 | - | 4.5 | 6 | 8 | 8.5 | 7.87 | 8.505 |
| Rate of return | 1.02% | - | 2.1% | 4.01% | 3.09% | 3.63% | 3.36% | 3.63% |
| EPS 2 | 4.98 | 6.24 | 5.67 | 5.67 | 8.71 | 9.13 | 9.795 | 10.95 |
| Distribution rate | 75.3% | - | 79.4% | 106% | 91.8% | 93.1% | 80.3% | 77.7% |
| Net sales 1 | 427.3 | 491.9 | 526.4 | 562.6 | 699.8 | 764 | 827 | 894.5 |
| EBITDA 1 | 139.7 | 164.5 | 155.1 | 155.6 | 221 | 242 | 262.5 | 291 |
| EBIT 1 | 116.3 | 141.3 | 131.4 | 131.1 | 196.2 | 217 | 233.5 | 262 |
| Net income 1 | 90.9 | 114 | 103.8 | 103.8 | 159.2 | 167 | 179 | 200.5 |
| Net Debt 1 | -112.4 | - | -46.1 | -154.2 | -174.6 | -139 | -152 | -175 |
| Reference price 2 | 367.50 | 231.00 | 214.00 | 149.50 | 259.00 | 234.00 | 234.00 | 234.00 |
| Nbr of stocks (in thousands) | 18,213 | 18,252 | 18,279 | 18,314 | 18,283 | 18,293 | - | - |
| Announcement Date | 2/25/22 | 3/1/23 | 2/29/24 | 2/28/25 | 2/27/26 | - | - | - |
1NOK in Million2NOK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 24.97x | 5.28x | 16.66x | 3.73% | 424M | |
| 26.21x | 4.72x | 18.18x | 0.35% | 195B | |
| 46.78x | 12.28x | 27.48x | -.--% | 151B | |
| 31.53x | - | - | 0.72% | 140B | |
| 16.58x | 3.44x | 11.09x | -.--% | 67.09B | |
| 33.65x | 7.54x | 23.96x | -.--% | 54.34B | |
| 18.43x | 2.12x | 10.92x | 2.85% | 44.63B | |
| 45.97x | 6.41x | 19.61x | -.--% | 37.24B | |
| 25.39x | 5.06x | 17.51x | 0.79% | 36.91B | |
| 19.78x | 5.2x | 13.42x | 1.16% | 30.24B | |
| Average | 28.93x | 5.78x | 17.65x | 0.96% | 75.64B | |
| Weighted average by Cap. | 31.20x | 6.64x | 19.48x | 0.48% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- MEDI Stock
- Valuation Medistim ASA
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
